학술논문

Phase I study to evaluate the safety, tolerability, and efficacy of VCN-01 in combination with durvalumab (MEDI4736) in subjects with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS1112-pS1112, 1p. Supplement: 7
Subject
Language
English
ISSN
15698041